Mitigating the impact of antibacterial drug resistance through host-directed therapies: Current progress, outlook, and challenges

mBio

Volumn 9, Issue 1, 2018, Pages

  Chiang, Chih Yuan ^a   Uzoma, Ijeoma ^a   Moore, Richard T ^a   Gilbert, Merle ^a   Duplantier, Allen J ^a   Panchal, Rekha G ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

Antibiotic resistance; Fluorescent image analysis; Inflammation; Innate immunity; Multidrug resistance; Proteomics

Indexed keywords

ANTIBIOTIC AGENT; HYPOXIA INDUCIBLE FACTOR; PATTERN RECOGNITION RECEPTOR; PHOSPHOTRANSFERASE; IMMUNOLOGIC FACTOR;

ANTIBIOTIC RESISTANCE; AUTOPHAGY; BACTERIAL CLEARANCE; BACTERIAL INFECTION; BACTERIAL LOAD; BACTERIAL SURVIVAL; BIOINFORMATICS; DRUG SCREENING; ENZYME ACTIVITY; FLUORESCENCE IMAGING; GENETIC SCREENING; HIGH THROUGHPUT SCREENING; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; IMAGE ANALYSIS; IMMUNOMODULATION; INFECTION CONTROL; INFLAMMATION; INNATE IMMUNITY; MULTIDRUG RESISTANCE; NONHUMAN; OXIDATION REDUCTION REACTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN STABILITY; PROTEOMICS; SHORT SURVEY; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TRANSCRIPTOMICS; BIOLOGY; DRUG DEVELOPMENT; TRENDS;

BACTERIAL INFECTIONS; COMPUTATIONAL BIOLOGY; DRUG DISCOVERY; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOLOGIC FACTORS;

EID: 85043493336     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01932-17     Document Type: Short Survey

References (98)

1. McGann P, Snesrud E, Maybank R, Corey B, Ong AC, Clifford R, Hinkle M, Whitman T, Lesho E, Schaecher KE. 2016. Escherichia coli harboring mcr-1 and blaCTX-M on a novel IncF plasmid: first report of mcr-1 in the United States. Antimicrob Agents Chemother 60:4420– 4421. https://doi.org/10.1128/AAC.01103-16.
2. Chen L, Todd R, Kiehlbauch J, Walters M, Kallen A. 2017. Notes from the field: pan-resistant New Delhi metallo-beta-lactamase-producing Klebsiella pneumoniae—Washoe County, Nevada, 2016. MMWR Morb Mortal Wkly Rep 66:33. https://doi.org/10.15585/mmwr.mm6601a7.
3. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268–281. https://doi.org/10.1111/j.1469-0691.2011.03570.x.
4. World Health Organization. 2014. Antimicrobial resistance: global report on surveillance 2014. World Health Organization, Geneva, Switzerland.
5. Hancock RE, Nijnik A, Philpott DJ. 2012. Modulating immunity as a therapy for bacterial infections. Nat Rev Microbiol 10:243–254. https://doi.org/10.1038/nrmicro2745.
6. Tamma PD, Cosgrove SE, Maragakis LL. 2012. Combination therapy for treatment of infections with gram-negative bacteria. Clin Microbiol Rev 25:450– 470. https://doi.org/10.1128/CMR.05041-11.
7. Di Russo Case E, Samuel JE. 2016. Contrasting lifestyles within the host cell. Microbiol Spectr 4(1). https://doi.org/10.1128/microbiolspec.VMBF -0014-2015.
8. Blackwell JM, Searle S, Goswami T, Miller EN. 2000. Understanding the multiple functions of Nramp1. Microbes Infect 2:317–321. https://doi.org/10.1016/S1286-4579(00)00295-1.
9. Mehra A, Zahra A, Thompson V, Sirisaengtaksin N, Wells A, Porto M, Köster S, Penberthy K, Kubota Y, Dricot A, Rogan D, Vidal M, Hill DE, Bean AJ, Philips JA. 2013. Mycobacterium tuberculosis type VII secreted effector EsxH targets host ESCRT to impair trafficking. PLoS Pathog 9:e1003734. https://doi.org/10.1371/journal.ppat.1003734.
10. van Schaik EJ, Chen C, Mertens K, Weber MM, Samuel JE. 2013. Molecular pathogenesis of the obligate intracellular bacterium Coxiella burnetii. Nat Rev Microbiol 11:561–573. https://doi.org/10.1038/nrmicro3049.
11. Bakowski MA, Braun V, Brumell JH. 2008. Salmonella-containing vacuoles: directing traffic and nesting to grow. Traffic 9:2022–2031. https://doi.org/10.1111/j.1600-0854.2008.00827.x.
12. Eswarappa SM, Negi VD, Chakraborty S, Chandrasekhar Sagar BK, Chakravortty D. 2010. Division of the Salmonella-containing vacuole and depletion of acidic lysosomes in Salmonella-infected host cells are novel strategies of Salmonella enterica to avoid lysosomes. Infect Immun 78:68–79. https://doi.org/10.1128/IAI.00668-09.
13. Ogawa M, Yoshimori T, Suzuki T, Sagara H, Mizushima N, Sasakawa C. 2005. Escape of intracellular Shigella from autophagy. Science 307: 727–731. https://doi.org/10.1126/science.1106036.
14. Cullinane M, Gong L, Li X, Lazar-Adler N, Tra T, Wolvetang E, Prescott M, Boyce JD, Devenish RJ, Adler B. 2008. Stimulation of autophagy suppresses the intracellular survival of Burkholderia pseudomallei in mammalian cell lines. Autophagy 4:744–753. https://doi.org/10.4161/auto.6246.
15. Butchar JP, Cremer TJ, Clay CD, Gavrilin MA, Wewers MD, Marsh CB, Schlesinger LS, Tridandapani S. 2008. Microarray analysis of human monocytes infected with Francisella tularensis identifies new targets of host response subversion. PLoS One 3:e2924. https://doi.org/10.1371/journal.pone.0002924.
16. Birmingham CL, Canadien V, Gouin E, Troy EB, Yoshimori T, Cossart P, Higgins DE, Brumell JH. 2007. Listeria monocytogenes evades killing by autophagy during colonization of host cells. Autophagy 3:442– 451. https://doi.org/10.4161/auto.4450.
17. Ray K, Marteyn B, Sansonetti PJ, Tang CM. 2009. Life on the inside: the intracellular lifestyle of cytosolic bacteria. Nat Rev Microbiol 7:333–340. https://doi.org/10.1038/nrmicro2112.
18. Whiteley L, Meffert T, Haug M, Weidenmaier C, Hopf V, Bitschar K, Schittek B, Kohler C, Steinmetz I, West TE, Schwarz S. 2017. Entry, intracellular survival, and multinucleated-giant-cell-forming activity of Burkholderia pseudomallei in human primary phagocytic and nonphagocytic cells. Infect Immun 85:e00468-17. https://doi.org/10.1128/IAI.00468-17.
19. Baxt LA, Garza-Mayers AC, Goldberg MB. 2013. Bacterial subversion of host innate immune pathways. Science 340:697–701. https://doi.org/10.1126/science.1235771.
20. Diacovich L, Gorvel JP. 2010. Bacterial manipulation of innate immunity to promote infection. Nat Rev Microbiol 8:117–128. https://doi.org/10.1038/nrmicro2295.
21. Satoh T, Akira S. 2016. Toll-like receptor signaling and its inducible proteins. Microbiol Spectr 4(6). https://doi.org/10.1128/microbiolspec.MCHD-0040-2016.
22. Takeuchi O, Akira S. 2010. Pattern recognition receptors and inflammation. Cell 140:805– 820. https://doi.org/10.1016/j.cell.2010.01.022.
23. Hirano T, Kodama S, Kawano T, Maeda K, Suzuki M. 2011. Monophos-phoryl lipid A induced innate immune responses via TLR4 to enhance clearance of nontypeable Haemophilus influenzae and Moraxella catarrhalis from the nasopharynx in mice. FEMS Immunol Med Microbiol 63:407– 417. https://doi.org/10.1111/j.1574-695X.2011.00866.x.
24. Bagnoli F, Fontana MR, Soldaini E, Mishra RP, Fiaschi L, Cartocci E, Nardi-Dei V, Ruggiero P, Nosari S, De Falco MG, Lofano G, Marchi S, Galletti B, Mariotti P, Bacconi M, Torre A, Maccari S, Scarselli M, Rinaudo CD, Inoshima N, Savino S, Mori E, Rossi-Paccani S, Baudner B, Pallaoro M, Swennen E, Petracca R, Brettoni C, Liberatori S, Norais N, Monaci E, Bubeck Wardenburg J, Schneewind O, O’Hagan DT, Valiante NM, Bensi G, Bertholet S, De Gregorio E, Rappuoli R, Grandi G. 2015. Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus. Proc Natl Acad Sci U S A 112:3680–3685. https://doi.org/10.1073/pnas.1424924112.
25. Saxena M, Yeretssian G. 2014. Nod-like receptors: master regulators of inflammation and cancer. Front Immunol 5:327. https://doi.org/10.3389/fimmu.2014.00327.
26. Rathinam VA, Vanaja SK, Fitzgerald KA. 2012. Regulation of inflammasome signaling. Nat Immunol 13:333–342. https://doi.org/10.1038/ni.2237.
27. Caruso R, Warner N, Inohara N, Núñez G. 2014. NOD1 and NOD2: signaling, host defense, and inflammatory disease. Immunity 41: 898–908. https://doi.org/10.1016/j.immuni.2014.12.010.
28. Guo H, Callaway JB, Ting JP. 2015. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med 21:677– 687. https://doi.org/10.1038/nm.3893.
29. Matusiak M, Van Opdenbosch N, Vande Walle L, Sirard JC, Kanneganti TD, Lamkanfi M. 2015. Flagellin-induced NLRC4 phosphorylation primes the inflammasome for activation by NAIP5. Proc Natl Acad Sci U S A 112:1541–1546. https://doi.org/10.1073/pnas.1417945112.
30. Ceballos-Olvera I, Sahoo M, Miller MA, Del Barrio L, Re F. 2011. Inflammasome-dependent pyroptosis and IL-18 protect against Burkholderia pseudomallei lung infection while IL-1beta is deleterious. PLoS Pathog 7:e1002452. https://doi.org/10.1371/journal.ppat.1002452.
31. Koh GC, Weehuizen TA, Breitbach K, Krause K, de Jong HK, Kager LM, Hoogendijk AJ, Bast A, Peacock SJ, van der Poll T, Steinmetz I, Wiersinga WJ. 2013. Glyburide reduces bacterial dissemination in a mouse model of melioidosis. PLoS Neglect Trop Dis 7:e2500. https://doi.org/10.1371/journal.pntd.0002500.
32. Liu X, Foo G, Lim WP, Ravikumar S, Sim SH, Win MS, Goh JG, Lim JH, Ng YH, Fisher D, Khoo CM, Tan G, Chai LY. 2014. Sulphonylurea usage in melioidosis is associated with severe disease and suppressed immune response. PLoS Negl Trop Dis 8:e2795. https://doi.org/10.1371/journal.pntd.0002795.
33. Kewcharoenwong C, Rinchai D, Utispan K, Suwannasaen D, Bancroft GJ, Ato M, Lertmemongkolchai G. 2013. Glibenclamide reduces proinflammatory cytokine production by neutrophils of diabetes patients in response to bacterial infection. Sci Rep 3:3363. https://doi.org/10.1038/srep03363.
34. Koh GC, Maude RR, Schreiber MF, Limmathurotsakul D, Wiersinga WJ, Wuthiekanun V, Lee SJ, Mahavanakul W, Chaowagul W, Chierakul W, White NJ, van der Poll T, Day NP, Dougan G, Peacock SJ. 2011. Glyburide is anti-inflammatory and associated with reduced mortality in melioidosis. Clin Infect Dis 52:717–725. https://doi.org/10.1093/cid/ciq192.
35. Coll RC, Robertson AA, Chae JJ, Higgins SC, Muñoz-Planillo R, Inserra MC, Vetter I, Dungan LS, Monks BG, Stutz A, Croker DE, Butler MS, Haneklaus M, Sutton CE, Núñez G, Latz E, Kastner DL, Mills KH, Masters SL, Schroder K, Cooper MA, O’Neill LA. 2015. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med 21:248–255. https://doi.org/10.1038/nm.3806.
36. Ryter SW, Cloonan SM, Choi AM. 2013. Autophagy: a critical regulator of cellular metabolism and homeostasis. Mol Cells 36:7–16. https://doi.org/10.1007/s10059-013-0140-8.
37. Deretic V, Saitoh T, Akira S. 2013. Autophagy in infection, inflammation and immunity. Nat Rev Immunol 13:722–737. https://doi.org/10.1038/nri3532.
38. Huang J, Brumell JH. 2014. Bacteria-autophagy interplay: a battle for survival. Nat Rev Microbiol 12:101–114. https://doi.org/10.1038/nrmicro 3160.
39. Mizushima N. 2007. Autophagy: process and function. Genes Dev 21: 2861–2873. https://doi.org/10.1101/gad.1599207.
40. Tjelle TE, Brech A, Juvet LK, Griffiths G, Berg T. 1996. Isolation and characterization of early endosomes, late endosomes and terminal lysosomes: their role in protein degradation. J Cell Sci 109:2905–2914.
41. Deretic V. 2012. Autophagy as an innate immunity paradigm: expanding the scope and repertoire of pattern recognition receptors. Curr Opin Immunol 24:21–31. https://doi.org/10.1016/j.coi.2011.10.006.
42. Lai SC, Devenish RJ. 2012. LC3-associated phagocytosis (LAP): connections with host autophagy. Cells 1:396– 408. https://doi.org/10.3390/cells1030396.
43. Rinchai D, Riyapa D, Buddhisa S, Utispan K, Titball RW, Stevens MP, Stevens JM, Ogawa M, Tanida I, Koike M, Uchiyama Y, Ato M, Lertmemongkolchai G. 2015. Macroautophagy is essential for killing of intracellular Burkholderia pseudomallei in human neutrophils. Autophagy 11:748–755. https://doi.org/10.1080/15548627.2015.1040969.
44. Webber JL, Tooze SA. 2010. Coordinated regulation of autophagy by p38alpha MAPK through mAtg9 and p38IP. EMBO J 29:27– 40. https://doi.org/10.1038/emboj.2009.321.
45. Stanley SA, Barczak AK, Silvis MR, Luo SS, Sogi K, Vokes M, Bray MA, Carpenter AE, Moore CB, Siddiqi N, Rubin EJ, Hung DT. 2014. Identification of host-targeted small molecules that restrict intracellular Mycobacterium tuberculosis growth. PLoS Pathog 10:e1003946. https://doi.org/10.1371/journal.ppat.1003946.
46. Kramer L, Turk D, Turk B. 2017. The future of cysteine cathepsins in disease management. Trends Pharmacol Sci 38:873– 898. https://doi.org/10.1016/j.tips.2017.06.003.
47. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA, Latz E. 2008. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9:847– 856. https://doi.org/10.1038/ni.1631.
48. Qi X, Man SM, Malireddi RK, Karki R, Lupfer C, Gurung P, Neale G, Guy CS, Lamkanfi M, Kanneganti TD. 2016. Cathepsin B modulates lysosomal biogenesis and host defense against Francisella novicida infection. J Exp Med 213:2081–2097. https://doi.org/10.1084/jem.20151938.
49. Schaffer K, Taylor CT. 2015. The impact of hypoxia on bacterial infection. FEBS J 282:2260–2266. https://doi.org/10.1111/febs.13270.
50. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, Johnson RS, Haddad GG, Karin M. 2008. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453:807– 811. https://doi.org/10.1038/nature06905.
51. Peyssonnaux C, Datta V, Cramer T, Doedens A, Theodorakis EA, Gallo RL, Hurtado-Ziola N, Nizet V, Johnson RS. 2005. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J Clin Invest 115: 1806–1815. https://doi.org/10.1172/JCI23865.
52. Lin AE, Beasley FC, Olson J, Keller N, Shalwitz RA, Hannan TJ, Hultgren SJ, Nizet V. 2015. Role of hypoxia inducible factor-1alpha (HIF-1alpha) in innate defense against uropathogenic Escherichia coli infection. PLoS Pathog 11:e1004818. https://doi.org/10.1371/journal.ppat.1004818.
53. Bhandari T, Nizet V. 2014. Hypoxia-inducible factor (HIF) as a pharmacological target for prevention and treatment of infectious diseases. Infect Dis Ther 3:159–174. https://doi.org/10.1007/s40121-014-0030-1.
54. Rastogi R, Geng X, Li F, Ding Y. 2016. NOX activation by subunit interaction and underlying mechanisms in disease. Front Cell Neurosci 10:301. https://doi.org/10.3389/fncel.2016.00301.
55. Lambeth JD. 2004. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4:181–189. https://doi.org/10.1038/nri1312.
56. Winterbourn CC, Hampton MB, Livesey JH, Kettle AJ. 2006. Modeling the reactions of superoxide and myeloperoxidase in the neutrophil phagosome: implications for microbial killing. J Biol Chem 281: 39860–39869. https://doi.org/10.1074/jbc.M605898200.
57. Fang FC. 2004. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol 2:820– 832. https://doi.org/10.1038/nrmicro1004.
58. Vatansever F, de Melo WC, Avci P, Vecchio D, Sadasivam M, Gupta A, Chandran R, Karimi M, Parizotto NA, Yin R, Tegos GP, Hamblin MR. 2013. Antimicrobial strategies centered around reactive oxygen species— bactericidal antibiotics, photodynamic therapy, and beyond. FEMS Microbiol Rev 37:955–989. https://doi.org/10.1111/1574-6976.12026.
59. Rabadi SM, Sanchez BC, Varanat M, Ma Z, Catlett SV, Melendez JA, Malik M, Bakshi CS. 2016. Antioxidant defenses of Francisella tularensis modulate macrophage function and production of proinflammatory cyto-kines. J Biol Chem 291:5009–5021. https://doi.org/10.1074/jbc.M115.681478.
60. Nathan C, Shiloh MU. 2000. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci U S A 97:8841– 8848. https://doi.org/10.1073/pnas.97.16.8841.
61. Vazquez-Torres A, Xu Y, Jones-Carson J, Holden DW, Lucia SM, Dinauer MC, Mastroeni P, Fang FC. 2000. Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. Science 287: 1655–1658. https://doi.org/10.1126/science.287.5458.1655.
62. Kuhns DB, Alvord WG, Heller T, Feld JJ, Pike KM, Marciano BE, Uzel G, DeRavin SS, Priel DA, Soule BP, Zarember KA, Malech HL, Holland SM, Gallin JI. 2010. Residual NADPH oxidase and survival in chronic granu-lomatous disease. N Engl J Med 363:2600–2610. https://doi.org/10.1056/NEJMoa1007097.
63. Pizzolla A, Hultqvist M, Nilson B, Grimm MJ, Eneljung T, Jonsson IM, Verdrengh M, Kelkka T, Gjertsson I, Segal BH, Holmdahl R. 2012. Reactive oxygen species produced by the NADPH oxidase 2 complex in monocytes protect mice from bacterial infections. J Immunol 188:5003–5011. https://doi.org/10.4049/jimmunol.1103430.
64. Zhang L, Li J, Zong L, Chen X, Chen K, Jiang Z, Nan L, Li X, Li W, Shan T, Ma Q, Ma Z. 2016. Reactive oxygen species and targeted therapy for pancreatic cancer. Oxid Med Cell Longev 2016:1616781. https://doi.org/10.1155/2016/1616781.
65. Lee CR, Zeldin DC. 2015. Resolvin infectious inflammation by targeting the host response. N Engl J Med 373:2183–2185. https://doi.org/10.1056/NEJMcibr1511280.
66. Dalli J, Chiang N, Serhan CN. 2015. Elucidation of novel 13-series re-solvins that increase with atorvastatin and clear infections. Nat Med 21:1071–1075. https://doi.org/10.1038/nm.3911.
67. Silva ON, de la Fuente-Núñez C, Haney EF, Fensterseifer IC, Ribeiro SM, Porto WF, Brown P, Faria-Junior C, Rezende TM, Moreno SE, Lu TK, Hancock RE, Franco OL. 2016. An anti-infective synthetic peptide with dual antimicrobial and immunomodulatory activities. Sci Rep 6:35465. https://doi.org/10.1038/srep35465.
68. Leroy Q, Raoult D. 2010. Review of microarray studies for host-intracellular pathogen interactions. J Microbiol Methods 81:81–95. https://doi.org/10.1016/j.mimet.2010.02.008.
69. Westermann AJ, Gorski SA, Vogel J. 2012. Dual RNA-seq of pathogen and host. Nat Rev Microbiol 10:618– 630. https://doi.org/10.1038/nrmicro 2852.
70. Jean Beltran PM, Federspiel JD, Sheng X, Cristea IM. 2017. Proteomics and integrative omic approaches for understanding host-pathogen interactions and infectious diseases. Mol Syst Biol 13:922. https://doi.org/10.15252/msb.20167062.
71. Chiang CY, Uzoma I, Lane DJ, Memišević V, Alem F, Yao K, Kota KP, Bavari S, Wallqvist A, Hakami RM, Panchal RG. 2015. A reverse-phase protein microarray-based screen identifies host signaling dynamics upon Burkholderia spp. infection. Front Microbiol 6:683. https://doi.org/10.3389/fmicb.2015.00683.
72. Eisenreich W, Heesemann J, Rudel T, Goebel W. 2013. Metabolic host responses to infection by intracellular bacterial pathogens. Front Cell Infect Microbiol 3:24. https://doi.org/10.3389/fcimb.2013.00024.
73. Bray MA, Singh S, Han H, Davis CT, Borgeson B, Hartland C, Kost-Alimova M, Gustafsdottir SM, Gibson CC, Carpenter AE. 2016. Cell painting, a high-content image-based assay for morphological profiling using multiplexed fluorescent dyes. Nat Protoc 11:1757–1774. https://doi.org/10.1038/nprot.2016.105.
74. Kota KP, Eaton B, Lane D, Ulrich M, Ulrich R, Peyser BD, Robinson CG, Jaissle JG, Pegoraro G, Bavari S, Panchal RG. 2013. Integrating high-content imaging and chemical genetics to probe host cellular pathways critical for Yersinia pestis infection. PLoS One 8:e55167. https://doi.org/10.1371/journal.pone.0055167.
75. Chiang CY, Ulrich RL, Ulrich MP, Eaton B, Ojeda JF, Lane DJ, Kota KP, Kenny TA, Ladner JT, Dickson SP, Kuehl K, Raychaudhuri R, Sun M, Bavari S, Wolcott MJ, Covell D, Panchal RG. 2015. Characterization of the murine macrophage response to infection with virulent and avirulent Burkholderia species. BMC Microbiol 15:259. https://doi.org/10.1186/s12866-015 -0593-3.
76. Serio AW, Jeng RL, Haglund CM, Reed SC, Welch MD. 2010. Defining a core set of actin cytoskeletal proteins critical for actin-based motility of Rickettsia. Cell Host Microbe 7:388–398. https://doi.org/10.1016/j.chom.2010.04.008.
77. Pegoraro G, Bavari S, Panchal RG. 2012. Shedding light on filovirus infection with high-content imaging. Viruses 4:1354–1371. https://doi.org/10.3390/v4081354.
78. Casanova A, Low SH, Emmenlauer M, Conde-Alvarez R, Salcedo SP, Gorvel JP, Dehio C. 2016. Microscopy-based assays for high-throughput screening of host factors involved in Brucella infection of Hela cells. J Vis Exp https://doi.org/10.3791/54263.
79. Poultney CS, Greenfield A, Bonneau R. 2012. Integrated inference and analysis of regulatory networks from multi-level measurements. Methods Cell Biol 110:19–56. https://doi.org/10.1016/B978-0-12-388403-9.00002-3.
80. Krachler AM, Woolery AR, Orth K. 2011. Manipulation of kinase signaling by bacterial pathogens. J Cell Biol 195:1083–1092. https://doi.org/10.1083/jcb.201107132.
81. Kuijl C, Savage ND, Marsman M, Tuin AW, Janssen L, Egan DA, Ketema M, van den Nieuwendijk R, van den Eeden SJ, Geluk A, Poot A, van der Marel G, Beijersbergen RL, Overkleeft H, Ottenhoff TH, Neefjes J. 2007. Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1. Nature 450:725–730. https://doi.org/10.1038/nature06345.
82. Albers HM, Kuijl C, Bakker J, Hendrickx L, Wekker S, Farhou N, Liu N, Blasco-Moreno B, Scanu T, den Hertog J, Celie P, Ovaa H, Neefjes J. 2014. Integrating chemical and genetic silencing strategies to identify host kinase-phosphatase inhibitor networks that control bacterial infection. ACS Chem Biol 9:414– 422. https://doi.org/10.1021/cb400421a.
83. Kierbel A, Gassama-Diagne A, Rocha C, Radoshevich L, Olson J, Mostov K, Engel J. 2007. Pseudomonas aeruginosa exploits a PIP3-dependent pathway to transform apical into basolateral membrane. J Cell Biol 177:21–27. https://doi.org/10.1083/jcb.200605142.
84. Frank CG, Reguerio V, Rother M, Moranta D, Maeurer AP, Garmendia J, Meyer TF, Bengoechea JA. 2013. Klebsiella pneumoniae targets an EGF receptor-dependent pathway to subvert inflammation. Cell Microbiol 15:1212–1233. https://doi.org/10.1111/cmi.12110.
85. Zhu J, Huang JW, Tseng PH, Yang YT, Fowble J, Shiau CW, Shaw YJ, Kulp SK, Chen CS. 2004. From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors. Cancer Res 64:4309– 4318. https://doi.org/10.1158/0008-5472.CAN-03 -4063.
86. Chiu HC, Soni S, Kulp SK, Curry H, Wang D, Gunn JS, Schlesinger LS, Chen CS. 2009. Eradication of intracellular Francisella tularensis in THP-1 human macrophages with a novel autophagy inducing agent. J Biomed Sci 16:110. https://doi.org/10.1186/1423-0127-16-110.
87. Lo JH, Kulp SK, Chen CS, Chiu HC. 2014. Sensitization of intracellular Salmonella enterica serovar Typhimurium to aminoglycosides in vitro and in vivo by a host-targeted antimicrobial agent. Antimicrob Agents Chemother 58:7375–7382. https://doi.org/10.1128/AAC.03778-14.
88. Chiu HC, Kulp SK, Soni S, Wang D, Gunn JS, Schlesinger LS, Chen CS. 2009. Eradication of intracellular Salmonella enterica serovar Typhimurium with a small-molecule, host cell-directed agent. Antimicrob Agents Chemother 53:5236–5244. https://doi.org/10.1128/AAC.00555-09.
89. Sutera V, Levert M, Burmeister WP, Schneider D, Maurin M. 2014. Evolution toward high-level fluoroquinolone resistance in Francisella spe- cies. J Antimicrob Chemother 69:101–110. https://doi.org/10.1093/jac/ dkt321.
90. Pielage JF, Powell KR, Kalman D, Engel JN. 2008. RNAi screen reveals an Abl kinase-dependent host cell pathway involved in Pseudomonas aeruginosa internalization. PLoS Pathog 4:e1000031. https://doi.org/10.1371/journal.ppat.1000031.
91. Qin QM, Pei J, Ancona V, Shaw BD, Ficht TA, de Figueiredo P. 2008. RNAi screen of endoplasmic reticulum-associated host factors reveals a role for IRE1alpha in supporting Brucella replication. PLoS Pathog 4:e1000110. https://doi.org/10.1371/journal.ppat.1000110.
92. Memišević V, Zavaljevski N, Pieper R, Rajagopala SV, Kwon K, Townsend K, Yu C, Yu X, DeShazer D, Reifman J, Wallqvist A. 2013. Novel Burkholderia mallei virulence factors linked to specific host-pathogen protein interactions. Mol Cell Proteomics 12:3036–3051. https://doi.org/10.1074/mcp.M113.029041.
93. Yang H, Ke Y, Wang J, Tan Y, Myeni SK, Li D, Shi Q, Yan Y, Chen H, Guo Z, Yuan Y, Yang X, Yang R, Du Z. 2011. Insight into bacterial virulence mechanisms against host immune response via the Yersinia pestis-human protein-protein interaction network. Infect Immun 79: 4413– 4424. https://doi.org/10.1128/IAI.05622-11.
94. Schweppe DK, Harding C, Chavez JD, Wu X, Ramage E, Singh PK, Manoil C, Bruce JE. 2015. Host-microbe protein interactions during bacterial infection. Chem Biol 22:1521–1530. https://doi.org/10.1016/j.chembiol.2015.09.015.
95. Harrison A, Dubois LG, St John-Williams L, Moseley MA, Hardison RL, Heimlich DR, Stoddard A, Kerschner JE, Justice SS, Thompson JW, Mason KM. 2016. Comprehensive proteomic and metabolomic signatures of nontypeable Haemophilus influenzae-induced acute otitis media reveal bacterial aerobic respiration in an immunosuppressed environment. Mol Cell Proteomics 15:1117–1138. https://doi.org/10.1074/mcp.M115.052498.
96. Czyż DM, Potluri LP, Jain-Gupta N, Riley SP, Martinez JJ, Steck TL, Crosson S, Shuman HA, Gabay JE. 2014. Host-directed antimicrobial drugs with broad-spectrum efficacy against intracellular bacterial pathogens. mBio 5:e01534-14. https://doi.org/10.1128/mBio.01534-14.
97. Brown D. 2015. Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void? Nat Rev Drug Discov 14:821– 832. https://doi.org/10.1038/nrd4675.
98. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, Finnerty CC, López CM, Honari S, Moore EE, Minei JP, Cuschieri J, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Jeschke MG, Klein MB, Gamelli RL, Gibran NS, Brownstein BH, Miller-Graziano C, Calvano SE, Mason PH, Cobb JP, Rahme LG, Lowry SF, Maier RV, Moldawer LL, Herndon DN, Davis RW, Xiao W, Tompkins RG, Inflammation and Host Response to Injury, Large Scale Collaborative Research Program. 2013. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 110:3507–3512. https://doi.org/10.1073/pnas.1222878110.